Coverage
-
July 14, 2020
A proposed shareholder class announced a settlement with Insys Therapeutics' former CEO in Arizona federal court Tuesday, which would resolve securities fraud claims over the company's alleged kickbacks to doctors who prescribed an addictive opioid spray.
2 other articles on this case.
View all »